EIKN
Eikon Therapeutics, Inc.
Company overview
- Market capitalization
- $428.45M
- Employees
- 384
- Latest publication
- 2026-09-29
About Eikon Therapeutics, Inc.
Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist designed to activate innate and adaptive immune anti-tumor responses; EIK1003 and EIK1004, which are selective PARP1 inhibitors in ovarian, breast, prostate, and pancreatic cancers and, specifically with the brain-penetrant; EIK1004 to address brain metastases and primary brain malignancies; EIK1005, a potent WRN helicase inhibitor and anti-tumor agent for MSI-high tumors; and EIK1006, a clinical candidate and next-generation androgen receptor antagonist with activity against multiple clinically emergent variants of androgen receptor. The company was incorporated in 2019 and is based in Millbrae, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 5,113,000USD | 5,105,000USD | — | — |
| Gross Profit | -5,113,000USD | -5,105,000USD | — | — |
| Research Development | 70,047,000USD | 65,229,000USD | 56,587,000USD | 53,860,000USD |
| Selling General Administrative | 17,290,000USD | 17,939,000USD | 14,796,000USD | 13,917,000USD |
| Unclassified Operating Expenses | -5,113,000USD | -5,105,000USD | — | — |
| Total Operating Expenses | 82,224,000USD | 78,063,000USD | 71,383,000USD | 67,777,000USD |
| Operating Income | -87,337,000USD | -83,168,000USD | -71,383,000USD | -67,777,000USD |
| Interest Income | 4,380,000USD | 3,474,000USD | 3,160,000USD | 2,855,000USD |
| Net Interest Income | 4,380,000USD | 3,522,000USD | 3,160,000USD | 2,848,000USD |
| Income Before Tax | -82,958,000USD | -79,655,000USD | -68,243,000USD | -64,924,000USD |
| Net Income | -82,958,000USD | -79,655,000USD | -68,243,000USD | -64,924,000USD |
| Net Income From Continuing Ops | -82,958,000USD | -79,655,000USD | -68,243,000USD | -64,924,000USD |
| Ebit | -87,337,000USD | -83,168,000USD | — | — |
| Ebitda | -82,224,000USD | -78,063,000USD | — | — |
| Depreciation And Amortization | 5,113,000USD | 5,105,000USD | — | — |
| Reconciled Depreciation | 5,113,000USD | 5,105,000USD | 6,466,000USD | 6,215,000USD |
| Total Other Income Expense Net | 4,379,000USD | 3,513,000USD | -20,000USD | 5,000USD |
| Interest Expense | — | 48,000USD | — | 7,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD |
|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD |
| Cost Of Revenue | 24,176,000USD | — | — |
| Gross Profit | -24,176,000USD | — | — |
| Research Development | 250,318,000USD | 204,536,000USD | 207,261,000USD |
| Selling General Administrative | 88,627,000USD | 55,807,000USD | 58,476,000USD |
| Unclassified Operating Expenses | -24,176,000USD | — | — |
| Total Operating Expenses | 314,769,000USD | 260,343,000USD | 265,737,000USD |
| Operating Income | -338,945,000USD | -260,343,000USD | -265,737,000USD |
| Interest Income | 15,566,000USD | 16,563,000USD | 23,737,000USD |
| Interest Expense | 837,000USD | 31,000USD | 39,000USD |
| Net Interest Income | 14,729,000USD | 16,532,000USD | 23,698,000USD |
| Income Before Tax | -324,248,000USD | -243,814,000USD | -241,997,000USD |
| Net Income | -324,248,000USD | -243,814,000USD | -241,997,000USD |
| Net Income From Continuing Ops | -324,248,000USD | -243,814,000USD | -241,997,000USD |
| Ebit | -338,945,000USD | — | — |
| Ebitda | -314,769,000USD | — | — |
| Depreciation And Amortization | 24,176,000USD | — | — |
| Reconciled Depreciation | 24,176,000USD | 25,392,000USD | 17,748,000USD |
| Total Other Income Expense Net | 14,697,000USD | -3,000USD | 42,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q4 20242024-12-31 · USD |
|---|---|---|---|---|---|
| Total Assets | 779,570,000USD | 850,826,000USD | 594,734,000USD | 642,337,000USD | 491,240,000USD |
| Cash And Equivalents | 142,613,000USD | — | — | — | — |
| Cash And Short Term Investments | 531,178,000USD | 512,582,000USD | 335,975,000USD | 375,854,000USD | — |
| Short Term Investments | 388,565,000USD | 351,028,000USD | 231,074,000USD | 270,986,000USD | 90,932,000USD |
| Total Current Assets | 546,978,000USD | 529,501,000USD | 348,917,000USD | 390,496,000USD | 227,889,000USD |
| Other Current Assets | 15,400,000USD | 16,919,000USD | 12,942,000USD | 14,642,000USD | 7,378,000USD |
| Other Non Current Assets | 539,000USD | — | — | — | — |
| Total Liabilities | 313,070,000USD | — | — | — | — |
| Total Current Liabilities | 55,296,000USD | 45,064,000USD | 55,007,000USD | 44,394,000USD | 56,449,000USD |
| Other Non Current Liabilities | 15,000,000USD | — | — | — | — |
| Total Stockholder Equity | 466,500,000USD | 550,671,000USD | -879,034,000USD | -804,354,000USD | -571,930,000USD |
| Total Equity Including Noncontrolling Interest | 466,500,000USD | — | — | — | — |
| Property Plant Equipment Net | 224,208,000USD | 229,133,000USD | 233,863,000USD | 241,150,000USD | 259,132,000USD |
| Accounts Payable | 6,564,000USD | 6,005,000USD | 681,000USD | 4,282,000USD | 17,578,000USD |
| Short Term Debt | 9,445,000USD | 9,740,000USD | 10,028,000USD | 9,905,000USD | — |
| Common Stock | 5,000USD | 5,000USD | — | — | — |
| Retained Earnings | -1,091,876,000USD | -1,003,467,000USD | -920,509,000USD | -840,854,000USD | -604,941,000USD |
| Total Liab | — | 300,155,000USD | 1,473,768,000USD | 1,446,691,000USD | 1,063,170,000USD |
| Other Current Liab | — | 29,319,000USD | 44,298,000USD | 30,207,000USD | 301,000USD |
| Capital Stock | — | 5,000USD | 0USD | 0USD | 0USD |
| Cash | — | 161,554,000USD | 104,901,000USD | 104,868,000USD | 129,179,000USD |
| Net Debt | — | 93,277,000USD | 152,418,000USD | 135,862,000USD | — |
| Short Long Term Debt Total | — | 254,831,000USD | 257,319,000USD | 240,730,000USD | — |
| Long Term Investments | — | 83,828,000USD | — | — | — |
| Property Plant Equipment Gross | — | 277,227,000USD | 276,777,000USD | 279,178,000USD | 293,034,000USD |
| Common Stock Shares Outstanding | — | 54,138,555shares | 54,138,555shares | 53,984,337shares | 53,984,337shares |
| Non Current Assets Total | — | 321,325,000USD | 245,817,000USD | 251,841,000USD | 263,351,000USD |
| Non Current Liabilities Total | — | 255,090,999USD | 1,418,761,000USD | 1,402,297,000USD | 1,006,721,000USD |
| Non Current Liabilities Other | — | 10,000,000USD | 10,000,000USD | 10,002,000USD | 5,348,000USD |
| Non Currrent Assets Other | — | 556,000USD | 11,954,000USD | 10,691,000USD | 4,219,000USD |
| Net Working Capital | — | 484,437,000USD | 293,910,000USD | 346,102,000USD | 171,440,000USD |
| Unclassified Non Current Assets | — | 7,808,000USD | — | — | — |
| Unclassified Non Current Liabilities | — | 245,090,999USD | 1,408,761,000USD | 1,392,295,000USD | 1,001,373,000USD |
| Unclassified Equity | — | 1,554,128,000USD | 41,475,000USD | 36,500,000USD | 33,011,000USD |
| Unclassified Current Liabilities | — | — | — | — | 38,570,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD |
|---|---|---|---|
| Total Assets | 594,734,000USD | 491,240,000USD | 525,705,000USD |
| Other Current Assets | 12,942,000USD | 7,378,000USD | 6,012,000USD |
| Total Liab | 1,473,768,000USD | 1,063,170,000USD | 867,078,000USD |
| Total Stockholder Equity | -879,034,000USD | -571,930,000USD | -341,373,000USD |
| Other Current Liab | 44,298,000USD | 301,000USD | 591,000USD |
| Capital Stock | 0USD | 0USD | 0USD |
| Retained Earnings | -920,509,000USD | -604,941,000USD | -361,127,000USD |
| Cash | 104,901,000USD | 129,179,000USD | 112,784,000USD |
| Cash And Short Term Investments | 335,975,000USD | — | — |
| Total Current Assets | 348,917,000USD | 227,889,000USD | 436,425,000USD |
| Total Current Liabilities | 55,007,000USD | 56,449,000USD | 31,440,000USD |
| Net Debt | 152,418,000USD | — | — |
| Short Term Debt | 10,028,000USD | — | — |
| Short Long Term Debt Total | 257,319,000USD | — | — |
| Short Term Investments | 231,074,000USD | 90,932,000USD | 317,629,000USD |
| Accounts Payable | 681,000USD | 17,578,000USD | 2,187,000USD |
| Property Plant Equipment Net | 233,863,000USD | 259,132,000USD | 86,880,000USD |
| Property Plant Equipment Gross | 276,777,000USD | 293,034,000USD | 105,775,000USD |
| Common Stock Shares Outstanding | 54,138,555shares | 53,984,337shares | 53,984,337shares |
| Non Current Assets Total | 245,817,000USD | 263,351,000USD | 89,279,000USD |
| Non Current Liabilities Total | 1,418,761,000USD | 1,006,721,000USD | 835,638,000USD |
| Non Current Liabilities Other | 10,000,000USD | 5,348,000USD | 730,000USD |
| Non Currrent Assets Other | 11,954,000USD | 4,219,000USD | 2,399,000USD |
| Net Working Capital | 293,910,000USD | 171,440,000USD | 404,985,000USD |
| Unclassified Non Current Liabilities | 1,408,761,000USD | 1,001,373,000USD | 834,908,000USD |
| Unclassified Equity | 41,475,000USD | 33,011,000USD | 19,754,000USD |
| Unclassified Current Liabilities | — | 38,570,000USD | 28,662,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 10,343,000USD |
| Stock Based Compensation | 6,996,000USD |
| Change To Liabilities | 10,821,000USD |
| Change In Working Capital | 5,821,000USD |
| Operating Cash Flow | -154,759,000USD |
| Capital Expenditures | -513,000USD |
| Net Investments | -156,275,000USD |
| Investing Cash Flow | -156,788,000USD |
| Financing Cash Flow | 349,333,000USD |
| Change In Cash | 37,786,000USD |
| End Cash Flow | 150,858,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD |
|---|---|---|---|---|
| Net Income | -82,958,000USD | -79,655,000USD | -68,243,000USD | -64,924,000USD |
| Depreciation | 5,113,000USD | 5,105,000USD | 6,466,000USD | 6,215,000USD |
| Stock Based Compensation | 2,777,000USD | 3,861,000USD | 2,970,000USD | 3,179,000USD |
| Other Non Cash Items | 1,950,000USD | -654,000USD | -1,234,000USD | -1,435,000USD |
| Change In Working Capital | -13,906,000USD | 29,619,000USD | 5,520,000USD | 33,225,000USD |
| Total Cash From Operating Activities | -89,801,000USD | -41,724,000USD | -54,521,000USD | -23,740,000USD |
| Capital Expenditures | -262,000USD | -66,000USD | -22,358,000USD | -39,518,000USD |
| Free Cash Flow | -90,063,000USD | -41,790,000USD | -76,879,000USD | -63,258,000USD |
| Investments | -202,955,000USD | 40,776,000USD | -191,496,000USD | 47,671,000USD |
| Total Cashflows From Investing Activities | -203,217,000USD | 40,710,000USD | — | — |
| Total Cash From Financing Activities | 349,308,000USD | 1,089,000USD | 350,234,000USD | 95,000USD |
| Issuance Of Capital Stock | 349,308,000USD | 1,089,000USD | 350,234,000USD | 95,000USD |
| Change In Cash | 56,253,000USD | 75,000USD | 81,859,000USD | -15,492,000USD |
| Begin Period Cash Flow | 105,301,000USD | 112,997,000USD | 130,878,000USD | 146,370,000USD |
| End Period Cash Flow | 161,554,000USD | 113,072,000USD | 212,737,000USD | 130,878,000USD |
| Unclassified Operating Cash Flow | -2,777,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD |
|---|---|---|---|
| Net Income | -324,248,000USD | -243,814,000USD | -241,997,000USD |
| Depreciation | 24,176,000USD | 25,392,000USD | 17,748,000USD |
| Stock Based Compensation | 18,036,000USD | 12,429,000USD | 9,538,000USD |
| Other Non Cash Items | 15,685,000USD | -9,456,000USD | 13,887,000USD |
| Change In Working Capital | 77,835,000USD | 80,650,000USD | 9,976,000USD |
| Total Cash From Operating Activities | -188,516,000USD | -134,799,000USD | -190,848,000USD |
| Capital Expenditures | -46,741,000USD | -84,803,000USD | -28,513,000USD |
| Free Cash Flow | -235,257,000USD | -219,602,000USD | -219,361,000USD |
| Investments | -134,602,000USD | 236,153,000USD | 165,463,000USD |
| Total Cashflows From Investing Activities | -181,343,000USD | — | — |
| Total Cash From Financing Activities | 352,053,000USD | 244,000USD | 105,812,000USD |
| Issuance Of Capital Stock | 352,053,000USD | 244,000USD | 105,812,000USD |
| Change In Cash | -17,806,000USD | 16,795,000USD | 51,914,000USD |
| Begin Period Cash Flow | 130,878,000USD | 114,083,000USD | 62,169,000USD |
| End Period Cash Flow | 113,072,000USD | 130,878,000USD | 114,083,000USD |
| Other Cashflows From Financing Activities | 350,153,000USD | — | — |
| Unclassified Financing Cash Flow | -350,153,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.